Company Filing History:
5 out of 11 
1 out of 3,221 
1 out of 832,812 Years Active: 1999-2010
Title: Innovations by Lawrence Luepschen: Advancements in Blood Coagulation Inhibition
Introduction
Lawrence Luepschen, an accomplished inventor based in Miami, FL, has contributed significantly to the field of biomedical innovations. With a portfolio that includes seven patents, his work primarily focuses on methods for inhibiting blood coagulation, showcasing his expertise in biotechnology and therapeutic development.
Latest Patents
Luepschen's most recent patents include pioneering methods for using antibodies to inhibit blood coagulation. This invention details how certain antibodies bind to native human Tissue Factor (TF) with high affinity and specificity, effectively preventing factor X from binding to TF or its complex, which can lead to reduced coagulation in vivo. This advancement holds promise for therapeutic applications, particularly in managing conditions related to undesired thrombosis.
Another notable patent features pharmaceutically active compounds and methods of treatment aimed at the prophylaxis of undesired thrombosis. The compounds and pharmaceutical compositions derived from this invention illustrate Luepschen's dedication to advancing medical treatments that can improve patient outcomes.
Career Highlights
Throughout his career, Luepschen has worked with prominent companies, including Sunol Molecular Corporation and Genentech, Inc. His experiences in these organizations have undoubtedly enhanced his expertise in the development and implementation of innovative medical technologies, solidifying his status as a key inventor in his field.
Collaborations
Luepschen has collaborated with talented professionals such as Hing C Wong and Esperanza Liliana Nieves. These partnerships have supported the advancement of his research and played a role in the successful development of his patented innovations.
Conclusion
Lawrence Luepschen exemplifies the spirit of innovation through his significant contributions to biomedicine, particularly in blood coagulation therapies. His inventions, patents, and collaborations continue to influence the industry and improve therapeutic options for many individuals facing health challenges related to coagulation disorders.